CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 34  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0801
LYS 10.0383
GLU 20.0202
LEU 30.0208
ARG 40.0172
CYS 50.0162
GLN 60.0193
CYS 70.0311
ILE 80.0515
LYS 90.0451
THR 100.0288
TYR 110.0232
SER 120.0308
LYS 130.0221
PRO 140.0270
PHE 150.0135
HIS 160.0174
PRO 170.0097
LYS 180.0164
PHE 190.0183
ILE 200.0133
LYS 210.0109
GLU 220.0149
LEU 230.0183
ARG 240.0201
VAL 250.0147
ILE 260.0045
GLU 270.0082
SER 280.0104
GLY 290.0231
PRO 300.0123
HIS 310.0080
CYS 320.0100
ALA 330.0167
ASN 340.0123
THR 350.0096
GLU 360.0074
ILE 370.0016
ILE 380.0126
VAL 390.0137
LYS 400.0229
LEU 410.0195
SER 420.0179
ASP 430.0356
GLY 440.0425
ARG 450.0394
GLU 460.0235
LEU 470.0130
CYS 480.0176
LEU 490.0140
ASP 500.0255
PRO 510.0184
LYS 520.0289
GLU 530.0291
ASN 540.0294
TRP 550.0240
VAL 560.0168
GLN 570.0175
ARG 580.0205
VAL 590.0094
VAL 600.0175
GLU 610.0363
LYS 620.0309
PHE 630.0274
LEU 640.0314
LYS 650.0299
ARG 660.0378
ALA 670.0416
GLU 680.0293
ASN 690.0801

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.